SISCAPA Assay Technologies
SISCAPA Assay Technologies

SISCAPA Assay Technologies Information

Contact top employees from SISCAPA Assay Technologies

Summary

SISCAPA Assay Technologies is a private company that has been in the industry for 14 years. The company currently specializes in the Biotechnology area. The position of the President & CEO is occupied by Gustavo Salem. Its headquarters is located at Washington, District of Columbia, USA. The number of employees ranges from 25 to 100. The annual revenue of SISCAPA Assay Technologies varies between 5.0M and 25M. Total funding of the company - $1M. To connect with SISCAPA Assay Technologies employee register on SignalHire.

Industries

Biotechnology

Headquarters Location

Employees Size

10-50 employees

Specialties

Proteome Quantitation, Immuno-MRM, Immuno-MS, SISCAPA, Protein Quantitation

DMA Code

Washington Metropolitan Area

Founded

2011

Estimated Annual Revenue

$5.0M - 25M

Operating Status

Independent Company

Contact SISCAPA Assay Technologies

Organization Website

Social Links

linkedIntwitter

Phone Number

301-728-1451

Employees Turnover 3 quarter 2025

Length of Employment
arrow
Employee tenure at SISCAPA Assay Technologies shows a diverse range of experience levels:
14% for 1–2 years14% for 3–4 years71% have over 11 years of service at SISCAPA Assay Technologies
Contact top employees from SISCAPA Assay Technologies
N Leigh Anderson
CEO and Co-founder
View
Richard Yip
Laboratory Operations Manager
View
Matt Pope
General Manager
View
Andrew Hettle
Staff Scientist
View

FAQ

SISCAPA Assay Technologies operates in the Biotechnology industries. More details can be found on the official website: siscapa.com.
The headquarters of SISCAPA Assay Technologies are located in Washington DC, United States.
The current CEO of SISCAPA Assay Technologies is Gustavo Salem
You can contact SISCAPA Assay Technologies by phone at 301-728-1451.
SISCAPA Assay Technologies currently employs 10-50 people.
SISCAPA Assay Technologies's revenue is approximately 18.7M.
BACK TO TOP